In this study, we report a significant statistical and clinical reduction by almost half (i.e., from 29.93%% down to 17.39%) in mortality related to sepsis in pediatric cases admitted to the PICU upon implementation of an EAS for SIRS/sepsis in an in-hospital setting. This finding is mainly attributed to the successful integration of the early identification of potential sepsis cases and prompt management. As observed in the literature, among all the interventions aimed at improving survival in patients with sepsis, fast recognition and the timely initiation of therapy, including antimicrobial administration, are the most important components [1, 2, 9, 10, 11, 12, 13]. Different approaches have been investigated to address the timely implementation of the recommended management. These have ranged from increasing awareness, enhancing education, and delegation to specialized teams to the implementation of a timely protocol or pathway [6, 14, 19]. Compliance with the Surviving Sepsis Campaign performance bundles, which include early recognition and intervention, was associated with a 25% relative risk reduction in mortality in patients with severe sepsis and septic shock [20]. Nevertheless, these bundles and protocols may not be consistent in improving mortality due to compliance variability and concern regarding the identification of zero time in the timeline protocol [6, 21]. Given that the diagnosis of potential sepsis cases is the cornerstone of therapeutic practice, a more structured and relatively objective approach is required to minimize human-related factors that could result in potential sepsis cases being missed. Such efforts led to the proposal of the PEWS system, which is widely accepted and has been validated in different settings with the potential benefit of identifying sepsis cases earlier and thus improving outcomes [1, 9, 22]. However, compliance with PEWS and integrated bundles requires reliable performance, high compliance, and regular audits, which could be challenging and resource demanding due to human factors [9, 17, 23]. The need for automated, effective, and timely screening tools for sepsis screening triggered further investment and investigations aimed at integrating health informatics and data analysis models [24, 25]. The growing interest in machine learning and big data analysis fueled this innovative approach, which resulted in the development of automated decisions-aiding models and electronic alerts for potential sepsis cases [3, 13, 24, 26, 27, 28, 29, 30, 21, 32, 33, 34, 35, 36].
Many challenges and limitations can be encountered during electronic alert development, including differences in adult and pediatric parameters, the presentation timing, and the variable phenotypes of sepsis and the underpinning genomics subgroups [35, 37, 38, 39, 40]. For instance, compared to adults, pediatric sepsis recognition is challenging due to the low specificity of tachycardia and tachypnea and the relatively late manifestation of hypotension [39]. Furthermore, many reports have addressed the validation of EAS use in the emergency department, which could be different compared to in-hospital settings [26, 27, 34, 40, 41, 42, 43]. These differences highlight the importance of accumulating more evidence to validate and support the EAS approach.
Although the early recognition of sepsis is invaluable, it must be accompanied by and integrated with appropriate therapeutic interventions to realize its essential value. Through these efforts multifaceted improvements in sepsis diagnosis and management will become more legitimate [3, 19, 44]. In our study, the implementation of a sepsis EAS was associated with a shorter time to receive a fluid bolus and the first dose of antibiotics. The average time to receiving the antibiotics from the EAS trigger was shorter by 1.7 hours (34.3%) and thus clinically relevant [2, 45, 46]. There were otherwise no changes in respiratory or hemodynamic support interventions. It is likely that the timely improvement in initial sepsis management with fluid and antibiotics, which was mediated by the sepsis EAS implementation, was associated with a reduction in mortality and LOS in PICU in our study. Similar findings were reported in a pediatric acute care setting where an analysis of the pre- and post-EAS implementation groups showed a reduction in both the 3-day sepsis-attributable mortality (2.53 vs. 0%] and 30-day mortality (3.8 vs. 1.3%) [32]. In adults, similar improvements in mortality and LOS outcomes have been associated with an EAS integrated with a multifaceted identification and intervention approach [3, 19]. An improvement in sepsis mortality has also been reported following the implementation of an EAS in an adult emergency setting [2, 13].
Another important outcome improvement in our study was the reduction in the mean number of organs affected in the post-EAS group. The marginal difference between the pre- and post-EAS groups with respect to the organs affected could explain the lack of a significant difference or change in respiratory, hemodynamic, and renal support between the groups. These clinical parameters likely did not reach statistical significance due to the relatively small sample used to detect differences in these variables as the study was powered to detect mortality differences as its primary outcome.
Although both groups in our study shared comparable basic characteristics in terms of gender, age, weight, and PRISM3 scores prior to enrollment in the study, the patients with hematology/oncology primary diseases were more prevalent than those with other diagnoses. This vulnerable population is likely to rapidly deteriorate when sepsis occurs, which may suggest that these patients could benefit from sepsis EAS implementation and that the cost-effectiveness ratio could become more favorable [23, 47, 48].
The impact of sepsis EAS could be further enhanced to include subcategories to decrease the signal’s noise for false or non-specific alerts. Identifying and focusing on specific alerts may help to improve the allocation of time and resources. For instance, Emmanuel et al. reported that the impact of alerts for potential device-associated infections resulted in more clinical interventions than less-specific alerts for central line-associated bloodstream infections, while neonatal sepsis alerts resulted in minimal interventions undertaken in response to alerts [28].
The findings of this hospital-wide study are important as they show a significant improvement in the patient survival rate following the addition of an EAS, which is the strategic goal for all healthcare facilities in general and in pediatric sepsis in particular. However, these results need to be interpreted with due consideration of their limitations. Different sepsis alert systems have been implemented by several healthcare institutes with the aim of improving the ability of healthcare practitioners to detect sepsis early and thus treat patients who meet the criteria for these alerts promptly. Notwithstanding, at present, no clear consensus exists on a single alert system as several barriers limit the wide implementation of a unified sepsis alert system. We believe that further studies testing such interventions are critical to reduce mortality in pediatric patients. In addition, further development of EASs are strongly recommended to improve the prognosis of pediatric sepsis as far as possible.